Lipe & Dalton’s Scotiabank BNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11K Hold
125
0.01% 94
2026
Q1
$9K Hold
125
﹤0.01% 92
2025
Q4
$9K Hold
125
﹤0.01% 95
2025
Q3
$8K Hold
125
﹤0.01% 93
2025
Q2
$7K Buy
+125
New +$6.36K ﹤0.01% 89
2025
Q1
Sell
-125
Closed -$7K 90
2024
Q4
$7K Hold
125
﹤0.01% 92
2024
Q3
$7K Buy
+125
New +$6.06K ﹤0.01% 101
2024
Q2
Sell
-125
Closed -$6K 99
2024
Q1
$6K Hold
125
﹤0.01% 105
2023
Q4
$6K Buy
+125
New +$5.5K ﹤0.01% 103
2023
Q3
Sell
-125
Closed -$6K 100
2023
Q2
$6K Sell
125
-450
-78% -$22.3K ﹤0.01% 101
2023
Q1
$29K Hold
575
0.02% 97
2022
Q4
$28K Hold
575
0.02% 95
2022
Q3
$27K Hold
575
0.02% 97
2022
Q2
$34K Hold
575
0.02% 93
2022
Q1
$41K Hold
575
0.02% 96
2021
Q4
$41K Hold
575
0.02% 101
2021
Q3
$35K Hold
575
0.02% 97
2021
Q2
$37K Hold
575
0.02% 99
2021
Q1
$36K Hold
575
0.02% 93
2020
Q4
$31K Buy
+575
New +$27.3K 0.02% 93

Other funds holding BNS

Lipe & Dalton's BNS Position: Q2 2026 in Review

Lipe & Dalton held its Scotiabank (BNS) position steady in Q2 2026 at 125 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #94.

Lipe & Dalton first reported a position in BNS in Q4 2020 and has held it in 20 quarters since. The position peaked at $41K in Q1 2022. 177 funds tracked by Wall St. Rank hold BNS as of Q2 2026.

  • Lipe & Dalton held 125 shares of Scotiabank worth $11K as of Q2 2026.
  • Lipe & Dalton left its Scotiabank share count unchanged in Q2 2026.
  • Scotiabank made up 0.01% of Lipe & Dalton's portfolio in Q2 2026, its #94 holding.
  • Lipe & Dalton first reported a position in Scotiabank in Q4 2020 and has held it in 20 quarters since.
  • Lipe & Dalton's Scotiabank position peaked at $41K in Q1 2022.
  • 177 funds tracked by Wall St. Rank held Scotiabank as of Q2 2026.

Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.